Company intelligence / Profile preview

FendX Technologies

Ontario, Canada

Ownership: Private
Development stage: Preclinical

Overview

Lead product REPELWRAP™ film has demonstrated the ability to repel bacteria and viruses from surfaces in laboratory settings. Pilot testing underway in real-world environments such as athletic facilities and senior care centers. No clinical trial data as this is a device/coating rather than a therapeutic drug.

Therapeutic areas: Infectious Diseases
Modalities: DeviceNanotechnology-based coating (film and spray)
Industry: Consumable Medical Devices

Drug pipeline

3 assets

REPELWRAP film

Pre-clinical

Indications: Surface contamination prevention

2 more assets in the full pipeline.

Request access →

Partnerships

McMaster University (R&D collaboration)Dunmore International (manufacturing/process optimization partner)

Beyond the preview

Go deeper on FendX Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FendX Technologies.

Explore the full profile